Designing a national combined reporting form for adverse drug reactions and medication errors

A Tanti1, A Serracino-Inglott1,2, J J Borg1,3

  • 1Medicines Authority, Gzira, Malta.

Insights

Malta developed a novel reporting form for adverse drug reactions (ADRs) and medication errors to meet EU pharmacovigilance standards. This system enhances data quality and can serve as a model for other countries.

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Public Health

Background:

  • European Union (EU) legislation mandates robust pharmacovigilance systems for public health.
  • The Maltese Medicines Authority required a system to capture high-quality data on adverse drug reactions (ADRs) and medication errors.
  • Existing reporting mechanisms needed improvement to meet regulatory and quality standards.

Purpose of the Study:

  • To describe the development and implementation of the first combined ADR and medication error reporting form in the EU.
  • To analyze reports generated by the new system and outline its promotion strategy.
  • To provide a replicable model for other countries seeking to enhance ADR and medication error reporting.

Main Methods:

  • A comprehensive review of existing ADR reporting forms was conducted.
  • Recommendations from European Medicines Agency and World Health Organization audits were integrated.
  • A new combined reporting form was developed, pilot-tested using case studies, and implemented within an ISO 9001 certified quality system.
  • A targeted promotion strategy was deployed to encourage healthcare professional adoption.

Main Results:

  • Successful introduction of the first combined ADR/medication error reporting form in the EU.
  • Establishment of a system for analyzing generated reports and promoting its use.
  • Redesign of the Authority's quality system to support the new reporting process.
  • Demonstration of the system's potential to improve data quality in ADR and medication error reporting.

Conclusions:

  • The Maltese experience offers a valuable framework for developing and implementing effective ADR and medication error reporting systems.
  • The combined reporting form enhances data capture quality, fulfilling public health obligations.
  • This model can guide other nations in improving their pharmacovigilance data collection and regulatory compliance.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
97
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
546
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
209
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.4K